Ratings Oneview Healthcare PLC

Equities

ONE

AU000000ONE9

Delayed Australian S.E. Other stock markets 22:30:36 2024-05-09 EDT			5-day change	1st Jan Change
0.305 ^AUD	+12.96%		+17.31%	+27.08%

04-23	Oneview Healthcare Posts 9% Rise in Net Operating Cashflow in March Quarter	MT
04-02	Oneview Healthcare Inks Master Services Agreement with Inova Health for 1,900 Beds	MT

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
The company has insufficient levels of profitability.
With an enterprise value anticipated at 7.81 times the sales for the current fiscal year, the company turns out to be overvalued.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Most analysts recommend that the stock should be sold or reduced.
Over the past four months, analysts' average price target has been revised downwards significantly.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Software

	1st Jan change	Capi.	ESG Refinitiv
ONEVIEW HEALTHCARE PLC	+27.08%	120M	-
ORACLE CORPORATION	+10.63%	323B	B-
SAP SE	+27.46%	220B	B+
SERVICENOW, INC.	+2.33%	148B	B
CONSTELLATION SOFTWARE INC.	+16.49%	59B	D+
FAIR ISAAC CORPORATION	+10.55%	30.92B	C+
HUBSPOT, INC.	+1.14%	30.04B	B+
MICROSTRATEGY INCORPORATED	+100.06%	21.87B	D+
WISETECH GLOBAL LIMITED	+27.42%	21.1B	B-
SAGE GROUP PLC	+2.86%	14.94B	B-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes